» Articles » PMID: 6209222

Mouse Monoclonal Antibodies Reactive with J5 Lipopolysaccharide Exhibit Extensive Serological Cross-reactivity with a Variety of Gram-negative Bacteria

Overview
Journal Infect Immun
Date 1984 Dec 1
PMID 6209222
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

We describe two mouse monoclonal antibodies reactive with lipopolysaccharide derived from the J5 mutant of Escherichia coli O111:B4. These antibodies react with purified lipopolysaccharide derived from rough mutants of E. coli and Salmonella typhimurium and also with lipopolysaccharide associated with both smooth- and rough-phenotype, gram-negative bacteria. Both antibodies appear to bind determinants present in the lipopolysaccharide core region, and this reactivity is inhibited in the presence of polymyxin B. Although their patterns of reactivity differ, both antibodies exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria. Reagents of this type should prove useful in animal models to delineate the requisite affinity, epitope specificity, immunoglobulin class, etc., needed for the prevention and treatment of gram-negative bacteremia.

Citing Articles

Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Salomao R, Rigato O, Pignatari A, Freudenberg M, Galanos C Infection. 1999; 27(1):1-11.

PMID: 10027099 DOI: 10.1007/BF02565163.


Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice.

Bailat S, Heumann D, Le Roy D, Baumgartner J, Rietschel E, Glauser M Infect Immun. 1997; 65(2):811-4.

PMID: 9009348 PMC: 176131. DOI: 10.1128/iai.65.2.811-814.1997.


Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide.

Warren H, Amato S, Fitting C, Black K, Loiselle P, Pasternack M J Exp Med. 1993; 177(1):89-97.

PMID: 8418211 PMC: 2190862. DOI: 10.1084/jem.177.1.89.


A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.

Di Padova F, Brade H, Barclay G, Poxton I, Liehl E, SCHUETZE E Infect Immun. 1993; 61(9):3863-72.

PMID: 8359907 PMC: 281087. DOI: 10.1128/iai.61.9.3863-3872.1993.


Monoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide.

de Kievit T, Lam J J Bacteriol. 1994; 176(23):7129-39.

PMID: 7525538 PMC: 197099. DOI: 10.1128/jb.176.23.7129-7139.1994.


References
1.
LUDERITZ O, STAUB A, Westphal O . Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae. Bacteriol Rev. 1966; 30(1):192-255. PMC: 378223. DOI: 10.1128/br.30.1.192-255.1966. View

2.
Galanos C, LUDERITZ O, Westphal O . A new method for the extraction of R lipopolysaccharides. Eur J Biochem. 1969; 9(2):245-9. DOI: 10.1111/j.1432-1033.1969.tb00601.x. View

3.
Hunter R . Standardization of the chloramine-T method of protein iodination. Proc Soc Exp Biol Med. 1970; 133(3):989-92. DOI: 10.3181/00379727-133-34611. View

4.
Galanos C, LUDERITZ O, Westphal O . Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. Eur J Biochem. 1971; 24(1):116-22. DOI: 10.1111/j.1432-1033.1971.tb19661.x. View

5.
Ziegler E, Douglas H, Sherman J, Davis C, BRAUDE A . Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant. J Immunol. 1973; 111(2):433-8. View